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Expression genetics and the phenotype 
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Many biologists have been struck by how 
preposterous it is to apply the term “post-
genomics” to any aspect of our ﬁ  eld. 
Estimates of gene number have ﬁ  nally set-
tled to a comfortably low asymptote, but the 
dam has broken on the RNA front, revealing 
an impressive level of ignorance and mystery. 
In an era in which fewer than 100 humans 
have been sequenced and the vast majority 
of species are represented by zero genomes, 
restraint or even humility is appropriate. Or 
maybe not. We are now venturing into new 
genomic territory made possible by ultra-
high throughput sequence.
In a recent paper, Adams, and colleagues 
(Sudbery et  al., 2009) tantalize us with 
what post-genomics might mean – when 
access to massive sequencing is taken for 
granted. The implications in neurogenom-
ics are enormous, and investigators would 
be well advised to track this new technol-
ogy and determine how best to exploit the 
new resources in their own research pro-
grams. This commentary brieﬂ  y reviews the 
Sudbery paper and a recent paper by Blakely 
and colleagues (Carneiro et al., 2009). The 
intent is to highlight likely repercussions 
of sequencing on the analysis of complex 
traits, including behavior.
In a cutting-edge approach, the Wellcome 
Trust Sanger team ﬂ  ow-sorted one of the 
most interesting mouse chromosomes  – 
chromosome 17, home of the major 
histocompatibility complex and many quan-
titative trait loci (QTLs) – from the genomes 
of two exceedingly different strains of mice, 
A/J and CAST/Ei. They sequenced these 
divergent versions of Chr 17 using a mas-
sively parallel sequencing system (Solexa) 
and applied a battery of genome assembly 
methods to stitch together 100 bp reads. 
In total they achieved coverage of between 
22 and 34× – enough to drench all but the 
most repetitive 1.5% of this chromosome in 
high quality sequence. Accomplishing this 
task took a few weeks of machine time, but 
was preceded by months of planning and 
sample preparation and followed by several 
months of intense assembly and analysis.
With sequences in hand, the group 
applied a sophisticated chain of algorithms 
(and independent validation) to systemati-
cally harvest large numbers of known and 
novel SNPs, indels, CNVs, and structural 
rearrangements. The gain in number of 
SNPs between A/J and the genome of the 
reference strain C57BL/6J was a modest 
30%. In contrast, the gain between CAST/
Ei and C57BL/6J was an impressive 35-
fold addition, with a harvest of 630,000 
new SNPs.
Readers of the paper by Sudbery et al. 
(2009) may fairly ask why did they sequence 
just one chromosome? The answer is that 
this is a large pilot project leading to a 
truly massive sequencing program. David 
Adams, the senior author, and colleagues 
are assembling genomes for 17 strains of 
mice – by far the largest effort of this kind 
in mouse genomics. Other groups, includ-
ing our own, are taking a focused approach, 
deeply sequencing key research strains (in 
our case DBA/2J, the other parent of the 
BXD family).
Now comes the fun part. Any practitioner 
of the dark art of QTL mapping knows that 
identifying causal sequence variants is the 
rate-limiting step that distinguishes QTL 
analysis from functional genomics. Various 
tricks – some clever and some just dirty – 
have been devised by the bright and the 
addled to make this process more efﬁ  cient. 
No doubt, the best friend of the hapless QTL 
cloner is excellent sequence data of parental 
strains and progeny. Illustrating this point, 
in the paper Sudbery et al. (2009) we are 
treated to comprehensive sequence-based 
dissection of a QTL that causes variation in 
liver triglyceride levels in a cross between 
A/J and C57BL/6J. By systematically work-
ing through all variants in a well-delimited 
QTL on Chr 17, the team efﬁ  ciently cut 
the list of high-caliber candidates down to 
three, of which one, Lmf1, is a gem previ-
ously linked to hypertriglyeridemia.
This result illustrates one of the most 
intriguing implications of this work: com-
plex trait analysis is transitioning from being 
a strictly forward genetic approach (from 
phenotype to gene) and is now   adopting 
reverse genetic methods similar to those 
used to study knockouts. As sequencing 
becomes cheaper, this transition will accel-
erate. Eventually, researchers interested 
in complex phenotypes – in other words, 
almost all of us – will use forward and 
reverse genetic methods with equal facil-
ity. In contrast to other methods, reverse 
complex trait analysis will often start with 
natural sequence variants rather than with 
engineered alleles or mutagenized stock.
Reverse complex trait analysis will still 
require large numbers of progeny (sets of 
recombinant inbred strains will be ideal), 
but the analysis will now be far more 
focused, as presaged in a recent paper by 
Carneiro et al. (2009) who hammered away 
at the functions of a crucial serotonin trans-
porter variant (5-HTT, Slc6a4) using as a 
resource a panel of 80 BXD strains made 
by crossing C57BL/6J and DBA/2J. Roughly 
half of the progeny strains have inherited 
the B allele, the other half the D allele. The 
result of combining sequence data with 
the BXD genetic reference panel is a robust 
and high-powered t test of the function of 
a known sequence variant. This is reverse 
genetics, functional genetics, and complex 
trait analysis rolled into one.
Many of us are already contemplating 
how to redesign and reinterpret genetic 
and functional experiments when the 
next wave of sequence data strikes, bring-
ing a compendium of ∼50 million murine 
sequence variants for our reading, review-
ing, and experimenting pleasure (Roberts 
et al., 2007). The analysis of a backlog of 
QTLs could be most rewarding, the analysis 
of thousands of previously hidden major 
alleles even more so.One last thought brings us back to the 
title of this commentary. The accelerating 
pace of progress in sequencing forces us to 
acknowledge the sharp transition that we 
are now entering – in essence, a genomics 
singularity that matches that in   computer 
science, in which each new generation 
of technology has exponentially greater 
throughput and can almost instantly rep-
licate all of what has gone before. In this 
environment, today’s cutting-edge paper 
is practically obsolete before publica-
tion. What will experimental genetics be 
like when genomes are almost free? These 
genomes will be a gift to both complex trait 
analysis and mutagenesis. In the end, there 
will just be a continuum between major and 
minor sequence variants, and the technolo-
gies used to ﬁ  nd them will be of minimal 
importance. In contrast, our success in 
understanding relations between sequence 
difference and phenotypes will depend 
critically on the precision and depth of 
phenotyping (Williams, 2006) and on the 
sophistication with which we can model the 
intricacies and contingencies of complex 
biological systems. Post-genomics may one 
day be relabeled systems genomics.
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